Tursi James Patrick 4
4 · Aralez Pharmaceuticals Inc. · Filed Mar 21, 2018
Insider Transaction Report
Form 4
Tursi James Patrick
Chief Medical Officer
Transactions
- Sale
Common Shares, without par value
2018-03-19$1.70/sh−5,950$10,115→ 251,400 total
Footnotes (1)
- [F1]This represents shares sold by the issuer on behalf of the reporting person pursuant to an instruction made in accordance with Rule 10b5-1 for payment of withholding tax liability incurred upon the vesting of 15,789 restricted stock units, which were previously granted on March 17, 2016 and which vested on March 17, 2018.